Business Context and Reporting Period
This Form 8-K was filed by Lipocine Inc. on June 10, 2022, reporting an event that occurred on June 7, 2022. The company is incorporated in Delaware and its common stock trades on The NASDAQ Capital Market under the symbol "LPCN".
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on a regulatory compliance matter regarding the company's stock price.
Material Changes
The material change reported is the receipt of a notice from the Nasdaq Listing Qualifications Department. The notice states that the bid price of Lipocine's common stock closed below the minimum $1.00 per share required for continued listing under Listing Rule 5550(a)(2) for the last 30 consecutive trading days.
Outlook, Risks, and Management Commentary
- Compliance Period: The company has been granted an initial 180-calendar-day compliance period to regain compliance, ending on December 5, 2022.
- Remediation Path: Compliance can be achieved if the closing bid price is at least $1.00 for a minimum of ten consecutive business days during the initial period.
- Secondary Compliance Period: If the company fails to regain compliance by December 5, 2022, it may be afforded a second 180-day period. Qualification for this period requires meeting the market value of publicly held shares and all other initial listing standards, excluding the minimum bid price requirement.
- Management Action: Management intends to actively monitor the stock price and consider available options to resolve the deficiency, which may include implementing a reverse stock split if necessary.
- Trading Status: The notice does not result in immediate delisting; the stock will continue to trade uninterrupted on NASDAQ.
Investor Verification Checklist
- Verify the current closing bid price of Lipocine Inc. (LPCN) to assess proximity to the $1.00 threshold.
- Monitor the company's stock price for ten consecutive business days to determine if the initial compliance requirement is met.
- Review future filings for announcements regarding a potential reverse stock split or other capital structure changes.
- Check the company's market value of publicly held shares to ensure eligibility for a potential second compliance period.